Physician profile
Daniel Tran
NPI 1427080647
$3,295.30
in general payments reported to CMS, 2019-2025
15 companies · $66.41 in 2025
The $66.41 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,433 · 2020: $125 · 2021: $1,197 · 2022: $210 · 2023: $214 · 2024: $51.06 · 2025: $66.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $331.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,317.60 | 2019-2021 | |
| Corcept Therapeutics | $161.05 | 2019-2025 | Korlym |
| Integra Lifesciences Corporation | $158.18 | 2020-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Smith+Nephew, INC. | $145.57 | 2022-2023 | Collagenase Santyl |
| Abbvie INC. | $122.55 | 2023 | Durysta |
| Davol INC. | $99.78 | 2022 | |
| Medtronic, INC. | $71.01 | 2021 | |
| Ethicon US, LLC | $62.71 | 2019-2025 | Echelon Endopath, Echelon Flex, Harmonic |
| Polynovo North America LLC | $28.68 | 2020 | |
| Tactile Systems Technology INC | $28.46 | 2020-2023 | Entre Plus, Flexitouch Plus |
| Allergan, INC. | $23.40 | 2021 | |
| Acell, INC. | $23.15 | 2019 | |
| Tela Bio, INC. | $21.88 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Endo Pharmaceuticals INC. | $16.28 | 2021 | |
| Bolder Surgical LLC | $15.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.